Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

Clicks: 395
ID: 120228
2010
PATH (GAVI Alliance grant) and Merck.
Reference Key
ge2010lancetefficacy Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Armah GE;Sow SO;Breiman RF;Dallas MJ;Tapia MD;Feikin DR;Binka FN;Steele AD;Laserson KF;Ansah NA;Levine MM;Lewis K;Coia ML;Attah-Poku M;Ojwando J;Rivers SB;Victor JC;Nyambane G;Hodgson A;Schödel F;Ciarlet M;Neuzil KM;;
Journal Lancet (London, England)
Year 2010
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/20692030
Keywords
Administration National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't Infant developing countries* Randomized Controlled Trial Antibodies Double-Blind Method Multicenter Study severity of illness index viral / blood gastroenteritis / virology rotavirus infections / prevention & control* vaccines attenuated / administration & dosage attenuated / immunology gastroenteritis / prevention & control* rotavirus / immunology rotavirus vaccines / administration & dosage* immunization schedule africa south of the sahara oral rotavirus infections / immunology immunoglobulin a / blood kathleen m neuzil pmid:20692030 doi:10.1016/s0140-6736(10)60889-6 george e armah samba o sow rotavirus vaccines / immunology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.